Cidara Therapeutics, Inc. - SIC # 2836 - BIOLOGICAL PRODUCTS, EXCEPT DIAGNOSTIC SUBSTANCES

Ticker Exchange SIC # Website Latest Ticker
CDTX Nasdaq 2836 www.cidara.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Cidara Therapeutics, Inc.

Warner Bros., Cidara, LENZ Therapeutics, and More Stocks See Action From Activist Investors - Jul 3rd, 2025 2:06 pm
Cidara Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - Jul 1st, 2025 2:59 pm
Cidara Therapeutics Announces Inclusion in the Russell 2000® and Russell 3000® Indexes - Jun 30th, 2025 6:00 am
Cidara Announces Closing of Upsized Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares - Jun 26th, 2025 3:15 pm
Cidara Announces Pricing of Upsized Public Offering of Common Stock - Jun 24th, 2025 6:00 pm
Cidara Therapeutics Flu Drug Seen as 'Potentially Transforming the Space', RBC Says - Jun 24th, 2025 10:35 am
Cidara Therapeutics Doubles As A Universal Flu Shot Becomes A Closer Reality - Jun 23rd, 2025 2:25 pm
Cidara Announces Proposed Public Offering of Common Stock - Jun 23rd, 2025 2:15 pm
Top Midday Gainers - Jun 23rd, 2025 12:12 pm
Cidara Therapeutics Announces Positive Topline Results from its Phase 2b NAVIGATE Trial Evaluating CD388, a Non-Vaccine Preventative of Seasonal Influenza - Jun 23rd, 2025 5:00 am
Cidara Therapeutics to Host Virtual R&D Day to Discuss CD388 as a Potential Universal, Once-Per-Flu Season Preventative of Seasonal and Pandemic Influenza on May 22, 2025 - May 15th, 2025 6:00 am
Cidara Therapeutics to Participate in Two Upcoming Investor Conferences - May 13th, 2025 6:00 am
Cidara Therapeutics Inc (CDTX) Q1 2025 Earnings Call Highlights: Promising Advances in ... - May 9th, 2025 1:48 am
Cidara Therapeutics: Q1 Earnings Snapshot - May 8th, 2025 2:38 pm
Cidara Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results - May 8th, 2025 2:15 pm
Cidara Therapeutics Announces Promotion of Nicole Davarpanah to Chief Medical Officer and Corrina Pavetto to SVP, Clinical Development - May 1st, 2025 6:00 am
Are You Looking for a Top Momentum Pick? Why Cidara Therapeutics (CDTX) is a Great Choice - Apr 30th, 2025 10:00 am
Cidara Therapeutics to Participate in The Citizens Life Sciences Conference - Apr 30th, 2025 6:00 am
Cidara Therapeutics to Report First Quarter 2025 Financial Results and Host Inaugural Quarterly Conference Call on May 8, 2025 - Apr 24th, 2025 6:00 am
Phathom Pharmaceuticals Appoints Ted Schroeder to its Board of Directors - Apr 16th, 2025 6:00 am